# ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy

> **NCT00004926** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DIETARY_SUPPLEMENT:** vitamin D3 analogue ILX23-7553

## Key facts

- **NCT ID:** NCT00004926
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2002-08
- **Final completion:** 2009-12
- **Target enrollment:** — (—)
- **Last updated:** 2013-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004926, "ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00004926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*